Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2022, Cilt: 52 Sayı: 3, 342 - 348, 30.12.2022
https://doi.org/10.26650/IstanbulJPharm.2022.1123242

Öz

Destekleyen Kurum

yoktur

Proje Numarası

yoktur

Teşekkür

yoktur

Kaynakça

  • Ateşman, E. (1997). Türkçede okunabilirliğin ölçülmesi. Dil Dergisi, 58(71-74).
  • Auwal, F. I., Tanimu, M., Samira, A.-A., & Hadiza, M. A. (2022). As- sessment of knowledge and attitude of undergraduate students’ of Ahmadu Bello University Zaria towards depression. İstanbul Journal of Pharmacy, 52(1), 96-100.
  • Ay, İ. E., & Duranoğlu, Y. (2022). Göz damlası prospektüslerinin okunabilirlik düzeyinin değerlendirilmesi. Anatolian Clinic the Journal of Medical Sciences, 27(1), 55-59.
  • Baker, D. W., Parker, R. M., Williams, M. V., & Clark, W. S. (1998). Health literacy and the risk of hospital admission. Journal of gen- eral internal medicine, 13(12), 791-798.
  • Bezirci, B., & Yilmaz, A. E. (2010). Metinlerin okunabilirliğinin ölçülmesi üzerine bir yazilim kütüphanesi ve Türkçe için yeni bir okunabilirlik ölçütü. Dokuz Eylül Üniversitesi Mühendislik Fakültesi Fen ve Mühendislik Dergisi, 12(3), 49-62.
  • Calkins, D. R., Davis, R. B., Reiley, P., Phillips, R. S., Pineo, K. L., Delbanco, T. L., & Iezzoni, L. I. (1997). Patient-physician communication at hos- pital discharge and patients’ understanding of the postdischarge treatment plan. Archives of Internal Medicine, 157(9), 1026-1030.
  • Desideri, I., Francolini, G., Ciccone, L., Stocchi, G., Salvestrini, V., Aquilano, M., . . . Scotti, V. (2021). Impact of COVID-19 on patient– doctor interaction in a complex radiation therapy facility. Sup- portive Care in Cancer, 29(6), 2931-2937.
  • Enlund, H., Vainio, K., Wallenius, S., & Poston, J. W. (1991). Adverse drug effects and the need for drug information. Medical care, 29(6), 558-564.
  • Erdoğan, Ö. N., & Araman, A. O. (2017). Health beliefs and func- tional health literacy; Interaction with the pharmaceutical ser- vices. İstanbul Journal of Pharmacy, 47(2), 68-71.
  • Ilbars, H., & Özkan, S. (2020). Understanding of Turkish pharma- cists health literacy knowledge, attitudes, and behavior. İstanbul Journal of Pharmacy, 50(1), 64-70.
  • Kanj, M., & Mitic, W. (2009). Promoting health and development: closing the implementation gap. Paper presented at the Unpub- lished conference document, 7th global conference on health promotion. Nairobi, Kenya: October.
  • Kitching, J. (1990). Patient information leaflets-the state of the art. Journal of the Royal Society of Medicine, 83(5), 298-300.
  • Makaryus, A. N., & Friedman, E. A. (2005). Patients’ understanding of their treatment plans and diagnosis at discharge. Mayo clinic proceedings, 80(8), 991-994.
  • Nielsen-Bohlman, L., Panzer, A. M., & Kindig, D. A. (2004). Health literacy: a prescription to end confusion. Washington, DC, USA: Na- tional Academies Press.
  • Philipson, S. J., Doyle, M. A., Gabram, S., Nightingale, C., & Philip- son, E. H. (1995). Informed consent for research: a study to evalu- ate readability and processability to effect change. Journal of in- vestigative medicine 43(5), 459-467.
  • Sağlık Bakanlığı. (2005). Beşeri Tıbbi Ürünler Ruhsatlandırma Yönetmeliği. Retrieved from https://www.resmigazete.gov.tr/es- kiler/2005/01/20050119-7.htm
  • Sağlık Bakanlığı. (2021). Türkiye İlaç Pazarı Gözlem Raporu-8 Satış Hacmi ve Değeri Açısından 2020 Yılı Pazar Durumu. Ankara: Sağlık Bakanlığı Yayınları.
  • Solak, E., & Bayar, A. (2015). Current challenges in English lan- guage learning in Turkish EFL context. Participatory Educational Research, 2(1), 106-115.
  • Türkiye İlaç ve Tıbbi Cihaz Kurumu. (2007). Kısa Ürün Bilgisine ilişkin Kılavuz. Retrieved from https://www.titck.gov.tr/mev- zuat/2103
  • Türkiye İlaç ve Tıbbi Cihaz Kurumu. (2008). Kullanma Talimatı Stan- dart Değerlendirme Prosedürü Retrieved from https://titck.gov. tr/storage/legislation/726b1e1355118.pdf
  • Türkiye İstatistik Kurumu. (2020). Türkiye İstatistikleri. Retrieved from https://www.tuik.gov.tr/media/announcements/turkiye_ istatistikleri_2020.pdf
  • Vishnevetsky, J., Walters, C. B., & Tan, K. S. (2018). Interrater reliabil- ity of the patient education materials assessment tool (PEMAT). Patient Education and Counseling, 101(3), 490-496.
  • Williams, M. V., Baker, D. W., Parker, R. M., & Nurss, J. R. (1998). Re- lationship of functional health literacy to patients’ knowledge of their chronic disease: a study of patients with hypertension and diabetes. Archives of Internal Medicine, 158(2), 166-172.

Evaluation of summary of product characteristics and patient information leaflet of the best-selling drugs in Turkey in terms of readability

Yıl 2022, Cilt: 52 Sayı: 3, 342 - 348, 30.12.2022
https://doi.org/10.26650/IstanbulJPharm.2022.1123242

Öz

Background and Aims: Readability can be defined as the easiness or difficulty of texts to be understood by readers. In our study, it was aimed to evaluate the patient information leaflet and the summary of product characteristics in terms of read- ability in Turkish.
Methods: Our study is a cross-sectional study. For our study, the best-selling drugs included in the "Turkish Pharmaceutical Market Monitoring Report-8, 2020 Market Status in Terms of Sales Volume and Value" prepared by the Turkish Medicines and Medical Devices Agency in 2021, were evaluated by using Turkish readability formulas (Ateşman and Bezirci-Yılmaz).
Results: 138 patient information leaflet and summary of product characteristics of a total of 69 products were evaluated. It has been determined that an average of at least undergraduate education is required for the readability of the texts. The patient information leaflets are significantly shorter than the summary of product characteristics (p=0.000). However, in terms of read- ability, it was easier in Ateşman calculation and more difficult in Bezirci-Yılmaz calculation (p=0.007 and p=0.000, respectively). Conclusion: It has been seen that patient information leaflets are not easy to read texts prepared for patients. While prepar- ing the texts to be read by the patients, the texts should be easily understandable and should be read and understood by people of all education levels.

Proje Numarası

yoktur

Kaynakça

  • Ateşman, E. (1997). Türkçede okunabilirliğin ölçülmesi. Dil Dergisi, 58(71-74).
  • Auwal, F. I., Tanimu, M., Samira, A.-A., & Hadiza, M. A. (2022). As- sessment of knowledge and attitude of undergraduate students’ of Ahmadu Bello University Zaria towards depression. İstanbul Journal of Pharmacy, 52(1), 96-100.
  • Ay, İ. E., & Duranoğlu, Y. (2022). Göz damlası prospektüslerinin okunabilirlik düzeyinin değerlendirilmesi. Anatolian Clinic the Journal of Medical Sciences, 27(1), 55-59.
  • Baker, D. W., Parker, R. M., Williams, M. V., & Clark, W. S. (1998). Health literacy and the risk of hospital admission. Journal of gen- eral internal medicine, 13(12), 791-798.
  • Bezirci, B., & Yilmaz, A. E. (2010). Metinlerin okunabilirliğinin ölçülmesi üzerine bir yazilim kütüphanesi ve Türkçe için yeni bir okunabilirlik ölçütü. Dokuz Eylül Üniversitesi Mühendislik Fakültesi Fen ve Mühendislik Dergisi, 12(3), 49-62.
  • Calkins, D. R., Davis, R. B., Reiley, P., Phillips, R. S., Pineo, K. L., Delbanco, T. L., & Iezzoni, L. I. (1997). Patient-physician communication at hos- pital discharge and patients’ understanding of the postdischarge treatment plan. Archives of Internal Medicine, 157(9), 1026-1030.
  • Desideri, I., Francolini, G., Ciccone, L., Stocchi, G., Salvestrini, V., Aquilano, M., . . . Scotti, V. (2021). Impact of COVID-19 on patient– doctor interaction in a complex radiation therapy facility. Sup- portive Care in Cancer, 29(6), 2931-2937.
  • Enlund, H., Vainio, K., Wallenius, S., & Poston, J. W. (1991). Adverse drug effects and the need for drug information. Medical care, 29(6), 558-564.
  • Erdoğan, Ö. N., & Araman, A. O. (2017). Health beliefs and func- tional health literacy; Interaction with the pharmaceutical ser- vices. İstanbul Journal of Pharmacy, 47(2), 68-71.
  • Ilbars, H., & Özkan, S. (2020). Understanding of Turkish pharma- cists health literacy knowledge, attitudes, and behavior. İstanbul Journal of Pharmacy, 50(1), 64-70.
  • Kanj, M., & Mitic, W. (2009). Promoting health and development: closing the implementation gap. Paper presented at the Unpub- lished conference document, 7th global conference on health promotion. Nairobi, Kenya: October.
  • Kitching, J. (1990). Patient information leaflets-the state of the art. Journal of the Royal Society of Medicine, 83(5), 298-300.
  • Makaryus, A. N., & Friedman, E. A. (2005). Patients’ understanding of their treatment plans and diagnosis at discharge. Mayo clinic proceedings, 80(8), 991-994.
  • Nielsen-Bohlman, L., Panzer, A. M., & Kindig, D. A. (2004). Health literacy: a prescription to end confusion. Washington, DC, USA: Na- tional Academies Press.
  • Philipson, S. J., Doyle, M. A., Gabram, S., Nightingale, C., & Philip- son, E. H. (1995). Informed consent for research: a study to evalu- ate readability and processability to effect change. Journal of in- vestigative medicine 43(5), 459-467.
  • Sağlık Bakanlığı. (2005). Beşeri Tıbbi Ürünler Ruhsatlandırma Yönetmeliği. Retrieved from https://www.resmigazete.gov.tr/es- kiler/2005/01/20050119-7.htm
  • Sağlık Bakanlığı. (2021). Türkiye İlaç Pazarı Gözlem Raporu-8 Satış Hacmi ve Değeri Açısından 2020 Yılı Pazar Durumu. Ankara: Sağlık Bakanlığı Yayınları.
  • Solak, E., & Bayar, A. (2015). Current challenges in English lan- guage learning in Turkish EFL context. Participatory Educational Research, 2(1), 106-115.
  • Türkiye İlaç ve Tıbbi Cihaz Kurumu. (2007). Kısa Ürün Bilgisine ilişkin Kılavuz. Retrieved from https://www.titck.gov.tr/mev- zuat/2103
  • Türkiye İlaç ve Tıbbi Cihaz Kurumu. (2008). Kullanma Talimatı Stan- dart Değerlendirme Prosedürü Retrieved from https://titck.gov. tr/storage/legislation/726b1e1355118.pdf
  • Türkiye İstatistik Kurumu. (2020). Türkiye İstatistikleri. Retrieved from https://www.tuik.gov.tr/media/announcements/turkiye_ istatistikleri_2020.pdf
  • Vishnevetsky, J., Walters, C. B., & Tan, K. S. (2018). Interrater reliabil- ity of the patient education materials assessment tool (PEMAT). Patient Education and Counseling, 101(3), 490-496.
  • Williams, M. V., Baker, D. W., Parker, R. M., & Nurss, J. R. (1998). Re- lationship of functional health literacy to patients’ knowledge of their chronic disease: a study of patients with hypertension and diabetes. Archives of Internal Medicine, 158(2), 166-172.
Toplam 23 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Eczacılık ve İlaç Bilimleri
Bölüm Original Article
Yazarlar

Ersan Gürsoy 0000-0002-5020-412X

Kenan Taştan 0000-0002-6020-1379

Mehmet Akif Nas 0000-0002-7843-3135

İdeal Beraa Yılmaz Kartal 0000-0002-3124-4898

Proje Numarası yoktur
Yayımlanma Tarihi 30 Aralık 2022
Gönderilme Tarihi 30 Mayıs 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 52 Sayı: 3

Kaynak Göster

APA Gürsoy, E., Taştan, K., Nas, M. A., Yılmaz Kartal, İ. B. (2022). Evaluation of summary of product characteristics and patient information leaflet of the best-selling drugs in Turkey in terms of readability. İstanbul Journal of Pharmacy, 52(3), 342-348. https://doi.org/10.26650/IstanbulJPharm.2022.1123242
AMA Gürsoy E, Taştan K, Nas MA, Yılmaz Kartal İB. Evaluation of summary of product characteristics and patient information leaflet of the best-selling drugs in Turkey in terms of readability. iujp. Aralık 2022;52(3):342-348. doi:10.26650/IstanbulJPharm.2022.1123242
Chicago Gürsoy, Ersan, Kenan Taştan, Mehmet Akif Nas, ve İdeal Beraa Yılmaz Kartal. “Evaluation of Summary of Product Characteristics and Patient Information Leaflet of the Best-Selling Drugs in Turkey in Terms of Readability”. İstanbul Journal of Pharmacy 52, sy. 3 (Aralık 2022): 342-48. https://doi.org/10.26650/IstanbulJPharm.2022.1123242.
EndNote Gürsoy E, Taştan K, Nas MA, Yılmaz Kartal İB (01 Aralık 2022) Evaluation of summary of product characteristics and patient information leaflet of the best-selling drugs in Turkey in terms of readability. İstanbul Journal of Pharmacy 52 3 342–348.
IEEE E. Gürsoy, K. Taştan, M. A. Nas, ve İ. B. Yılmaz Kartal, “Evaluation of summary of product characteristics and patient information leaflet of the best-selling drugs in Turkey in terms of readability”, iujp, c. 52, sy. 3, ss. 342–348, 2022, doi: 10.26650/IstanbulJPharm.2022.1123242.
ISNAD Gürsoy, Ersan vd. “Evaluation of Summary of Product Characteristics and Patient Information Leaflet of the Best-Selling Drugs in Turkey in Terms of Readability”. İstanbul Journal of Pharmacy 52/3 (Aralık 2022), 342-348. https://doi.org/10.26650/IstanbulJPharm.2022.1123242.
JAMA Gürsoy E, Taştan K, Nas MA, Yılmaz Kartal İB. Evaluation of summary of product characteristics and patient information leaflet of the best-selling drugs in Turkey in terms of readability. iujp. 2022;52:342–348.
MLA Gürsoy, Ersan vd. “Evaluation of Summary of Product Characteristics and Patient Information Leaflet of the Best-Selling Drugs in Turkey in Terms of Readability”. İstanbul Journal of Pharmacy, c. 52, sy. 3, 2022, ss. 342-8, doi:10.26650/IstanbulJPharm.2022.1123242.
Vancouver Gürsoy E, Taştan K, Nas MA, Yılmaz Kartal İB. Evaluation of summary of product characteristics and patient information leaflet of the best-selling drugs in Turkey in terms of readability. iujp. 2022;52(3):342-8.